AlphaMark Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-5,753
| Closed | -$13K | – | 590 |
|
|
2020
Q2 | $13K | Buy |
5,753
+600
| +12% | +$1.36K | 0.01% | 331 |
|
|
2020
Q1 | $9K | Buy |
+5,153
| New | +$9K | 0.01% | 317 |
|
|
2019
Q4 | – | Sell |
-5,000
| Closed | -$15K | – | 530 |
|
|
2019
Q3 | $15K | Hold |
5,000
| – | – | 0.01% | 293 |
|
|
2019
Q2 | $20K | Sell |
5,000
-8
| -0.2% | -$32 | 0.01% | 274 |
|
|
2019
Q1 | $24K | Hold |
5,008
| – | – | 0.01% | 243 |
|
|
2018
Q4 | $11K | Hold |
5,008
| – | – | 0.01% | 307 |
|
|
2018
Q3 | $31K | Buy |
5,008
+2,518
| +101% | +$15.6K | 0.01% | 255 |
|
|
2018
Q2 | $17K | Hold |
2,490
| – | – | 0.01% | 315 |
|
|
2018
Q1 | $21K | Sell |
2,490
-34,002
| -93% | -$287K | 0.01% | 280 |
|
|
2017
Q4 | $339K | Sell |
36,492
-1,619
| -4% | -$15K | 0.13% | 89 |
|
|
2017
Q3 | $445K | Hold |
38,111
| – | – | 0.19% | 74 |
|
|
2017
Q2 | $1.59M | Hold |
38,111
| – | – | 0.68% | 43 |
|
|
2017
Q1 | $1.86M | Buy |
38,111
+8
| +0% | +$390 | 0.86% | 40 |
|
|
2016
Q4 | $1.26M | Buy |
38,103
+9,750
| +34% | +$321K | 0.65% | 41 |
|
|
2016
Q3 | $1.16M | Buy |
28,353
+10
| +0% | +$409 | 0.59% | 41 |
|
|
2016
Q2 | $930K | Hold |
28,343
| – | – | 0.55% | 47 |
|
|
2016
Q1 | $1.76M | Buy |
+28,343
| New | +$1.76M | 0.93% | 38 |
|